Kamakee Dialysis (Davita Ocean County Dc) is a medicare approved dialysis facility center in Toms River, New Jersey and it has 9 dialysis stations. It is located in Ocean county at 635 Bay Avenue Suite 215, Toms River, NJ, 08753. You can reach out to the office of Kamakee Dialysis (Davita Ocean County Dc) at (732) 341-2730. This dialysis clinic is managed and/or owned by Davita. Kamakee Dialysis (Davita Ocean County Dc) has the following ownership type - Profit. It was first certified by medicare in October, 2016. The medicare id for this facility is 312661 and it accepts patients under medicare ESRD program.
| Name | Kamakee Dialysis (Davita Ocean County Dc) |
|---|---|
| Location | 635 Bay Avenue Suite 215, Toms River, New Jersey |
| No. of Dialysis Stations | 9 |
| Medicare ID | 312661 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 635 Bay Avenue Suite 215, Toms River, New Jersey, 08753 | |
| (732) 341-2730 | |
| Not Available |
News Archive
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
Medical Data Consultants, Inc. a leading Medical Coding & Billing firm, is pleased to announce that they have been awarded GSA Schedule 520 contract (GS-23F-057BA) and are now certified to supply Medical Coding & Billing Services to the Federal Government.
› Verified 7 days ago
| NPI Number | 1083086029 |
| Organization Name | Ocean County Dialysis |
| Doing Business As | Kamakee Dialysis Llc |
| Address | 635 Bay Ave Toms River, New Jersey, 08753 |
| Phone Number | (732) 341-2730 |
News Archive
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
Medical Data Consultants, Inc. a leading Medical Coding & Billing firm, is pleased to announce that they have been awarded GSA Schedule 520 contract (GS-23F-057BA) and are now certified to supply Medical Coding & Billing Services to the Federal Government.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 6 |
News Archive
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
Medical Data Consultants, Inc. a leading Medical Coding & Billing firm, is pleased to announce that they have been awarded GSA Schedule 520 contract (GS-23F-057BA) and are now certified to supply Medical Coding & Billing Services to the Federal Government.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 15 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 87 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
Medical Data Consultants, Inc. a leading Medical Coding & Billing firm, is pleased to announce that they have been awarded GSA Schedule 520 contract (GS-23F-057BA) and are now certified to supply Medical Coding & Billing Services to the Federal Government.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Kamakee Dialysis (Davita Ocean County Dc) with elevated calcium levels.
| Patients with hypercalcemia | 15 |
| Hypercalcemia patient months | 89 |
| Patients with Serumphosphor | 17 |
| Patients with Serumphosphor less than 3.5 mg/dL | 14 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 31 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 15 |
| Patients with Serumphosphor greater than 7 mg/dL | 6 |
News Archive
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
Medical Data Consultants, Inc. a leading Medical Coding & Billing firm, is pleased to announce that they have been awarded GSA Schedule 520 contract (GS-23F-057BA) and are now certified to supply Medical Coding & Billing Services to the Federal Government.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 35 |
| Patient months included in arterial venous fistula and catheter summaries | 117 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 65 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
Medical Data Consultants, Inc. a leading Medical Coding & Billing firm, is pleased to announce that they have been awarded GSA Schedule 520 contract (GS-23F-057BA) and are now certified to supply Medical Coding & Billing Services to the Federal Government.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 3 |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.
Medical Data Consultants, Inc. a leading Medical Coding & Billing firm, is pleased to announce that they have been awarded GSA Schedule 520 contract (GS-23F-057BA) and are now certified to supply Medical Coding & Billing Services to the Federal Government.
› Verified 7 days ago